RNA regulation and cancer development
Language English Country Ireland Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
16675105
DOI
10.1016/j.canlet.2006.03.021
PII: S0304-3835(06)00191-1
Knihovny.cz E-resources
- MeSH
- Alternative Splicing MeSH
- RNA Editing MeSH
- Humans MeSH
- RNA, Messenger genetics metabolism MeSH
- Models, Genetic MeSH
- Neoplasms genetics pathology MeSH
- Gene Expression Regulation * MeSH
- RNA Interference MeSH
- RNA Stability MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- RNA, Messenger MeSH
Cancer is viewed as a genetic disease. According to the currently accepted model of carcinogenesis, several consequential mutations in oncogenes or tumor suppressor genes are necessary for cancer development. In this model, mutated DNA sequence is transcribed to mRNA that is finally translated into functionally aberrant protein. mRNA is viewed solely as an intermediate between DNA (with 'coding' potential) and protein (with 'executive' function). However, recent findings suggest that (m)RNA is actively regulated by a variety of processes including nonsense-mediated decay, alternative splicing, RNA editing or RNA interference. Moreover, RNA molecules can regulate a variety of cellular functions through interactions with RNA, DNA as well as protein molecules. Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis. Here, we summarize recent knowledge on RNA-related processes and discuss their potential role in cancer development.
References provided by Crossref.org